Follow
Chimeric antigens
Antigens are foreign substances that induce the body to generate an immune response and produce antibodies. The better the immune system can recognize antigens, the more effective immune response it can mount. Chimeric antigens are specially engineered proteins that designed to improve the ability of immune cells to target a specific disease-associated antigen.
What's Popular in Chimeric antigens
-
MAR 04, 2024Cell & Molecular Biology
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals availab ...Sponsored By: Single Use SupportFEB 29, 2024Immunology
Jennifer Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in g ...Written By: Brian G. MorrealeFEB 22, 2024Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as ...Written By: Brian G. MorrealeFEB 15, 2024Immunology
There are various ways to treat cancer. The gold standard has been chemotherapy for over 50-years. However, treatment wi ...Written By: Brian G. MorrealeFEB 08, 2024Immunology
Summary: Engineered immune cells, known as T cells, were found to eliminate anti-immune cells connected to age-associate ...Written By: Brian G. Morreale
MAR 04, 2024
Cell & Molecular Biology
With astonishing advances in molecular biology, cell and gene therapies represent a new class of pharmaceuticals availab
...
Sponsored By:
Single Use Support
FEB 29, 2024
Immunology
Jennifer Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in g
...
Written By:
Brian G. Morreale
FEB 22, 2024
Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as
...
Written By:
Brian G. Morreale
FEB 15, 2024
Immunology
There are various ways to treat cancer. The gold standard has been chemotherapy for over 50-years. However, treatment wi
...
Written By:
Brian G. Morreale
FEB 08, 2024
Immunology
Summary: Engineered immune cells, known as T cells, were found to eliminate anti-immune cells connected to age-associate
...
Written By:
Brian G. Morreale
DEC 14, 2023
Immunology
A novel immune cell therapy known as Chimeric Antigen Receptor (CAR) T cell therapy has recently demonstrated efficacy i
...
Written By:
Brian G. Morreale
NOV 30, 2023
Immunology
Engineered immune cells have been the topic of investigation for the last few decades. Just 11 years ago a child was tre
...
Written By:
Brian G. Morreale
NOV 29, 2023
Cancer
The CAR-T Revolution: Developing T Cells into Cancer Assassins Cancer has long been a formidable foe, but recent
...
NOV 08, 2023
Cancer
Adoptive cell therapy has emerged as a promising alternative treatment for hematological and solid cancers, with CAR-T t
...
Sponsored By:
Sino Biological
-
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....NOV 07, 2023 | 10:00 AM
In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...SEP 28, 2023 | 7:00 AM
Webinars will be available for unlimited on-demand viewing after live event. Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the AS...JUL 26, 2023 | 3:10 PM
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
JUL 26, 2023 | 11:20 AM
Chimeric antigen receptor (CAR)-reprogrammed immune cells offer exciting therapeutic potential for addressing oncology, autoimmune diseases, transplant medicine, and infections. However, cur...
Speaker:
Dr. Dimitrios L. Wagner
Presented at: GenScript 3rd Annual Gene and Cell Engineering Summit
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....
NOV 07, 2023 | 10:00 AM
In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...
SEP 28, 2023 | 7:00 AM
Webinars will be available for unlimited on-demand viewing after live event. Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the AS...
JUL 26, 2023 | 3:10 PM
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
JUL 26, 2023 | 11:20 AM
Chimeric antigen receptor (CAR)-reprogrammed immune cells offer exciting therapeutic potential for addressing oncology, autoimmune diseases, transplant medicine, and infections. However, cur...
Speaker:
Dr. Dimitrios L. Wagner
Presented at: GenScript 3rd Annual Gene and Cell Engineering Summit
MAY 16, 2023 | 8:00 AM
The therapeutic use of chimeric antigen receptor T cells has achieved significant success in the treatment of B cells malignancies. Despite promising results in mouse tumor models, a similar...
MAR 30, 2023 | 5:00 PM
Date: March 30, 2023 Time: 5:00pm (PST), 8:00pm (EST) March 31, 2023 9:00am (JST) Chimeric antigen receptor T cell (CAR-T) therapy is still challenging in targeting solid malignancies. The q...
DEC 09, 2021 | 8:00 AM
Date: December 9, 2021 Time: 8:00am (PDT), 11:00am (EDT) Engineering human regulatory T cells (Tregs) with a chimeric antigen receptor (CAR) targeting donorderived human leukocyte antigen (H...
OCT 07, 2021 | 11:55 PM
Summary: Cancer neoantigens are highly specific to the tumor, potently immunogenic and can be targeted by both vaccines and engineered cellular therapies. This talk will introduce the defini...
-
JUL 26, 2023 | 8:00 AM PDT
GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, le...JUL 28, 2022 | 8:00 AM PDT
GenScript is delighted to announce its 2nd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, lev...OCT 06, 2021 | 5:30 AM PDT
Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 9th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...SEP 22, 2021 | 5:30 AM PDT
Labroots and the Cell Biology Planning Committee are pleased to announce the 5th Annual Event in the Cell Biology Virtual Event Series, providing an opportunity to...SEP 08, 2021 | 6:00 AM PDT
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
JUL 26, 2023
| 8:00 AM PDT
GenScript is delighted to announce its 3rd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, le...
JUL 28, 2022
| 8:00 AM PDT
GenScript is delighted to announce its 2nd Annual Virtual Summit on Gene and Cell Engineering. This gathering will feature leaders in the life sciences from academia, pharma, and biotech, lev...
OCT 06, 2021
| 5:30 AM PDT
Labroots and the Cancer Research and Oncology Planning Committee are pleased to announce the 9th Annual Event in the Cancer Research & Oncology Week Virtual Event Series!...
SEP 22, 2021
| 5:30 AM PDT
Labroots and the Cell Biology Planning Committee are pleased to announce the 5th Annual Event in the Cell Biology Virtual Event Series, providing an opportunity to...
SEP 08, 2021
| 6:00 AM PDT
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
JUL 22, 2021
| 5:00 AM PDT
Gene and cell engineering advances have influenced almost all branches of life sciences. From the lab to the clinic, innovative gene synthesis technologies and gene editing tools have transf...
JUN 02, 2021
| 5:30 AM PDT
Labroots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event Series taking place on June 2, 2021. Immuno-oncology is considered by some to be...
APR 07, 2021
| 6:30 AM PDT
Accelerating Cell and Gene Therapy Treatments Since the first approved gene therapy trial in 1990, interest in cell and gene therapies has increased rapidly, changing the course of research...
NOV 10, 2020
| 8:00 AM
Join us for presentations by scientists from leading labs in immuno-oncology, drug discovery, cell line development, and 3D/PDO models. Learn how to conduct modern cell-based assays with var...